Media reporting of tenofovir trials in Cambodia and Cameroon

BMC International Health and Human Rights

Volumn 5, Issue , 2005, Pages

  Mills, Edward ^a,b   Rachlis, Beth ^a   Wu, Ping ^c   Wong, Elaine ^d   Wilson, Kumanan ^e   Singh, Sonal ^f  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^e UNIVERSITY OF TORONTO   (Canada)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CAMBODIA; CAMEROON; CLINICAL TRIAL; COUNSELING; DATA BASE; ELECTRONICS; ETHICS; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION; INJURY; INTERNET; INTERVIEW; MASS MEDIUM; MEDICAL RESEARCH; PROPHYLAXIS; RISK ASSESSMENT; VALIDATION PROCESS;

EID: 26444529969     PISSN: 1472698X     EISSN: 1472698X     Source Type: Journal    
DOI: 10.1186/1472-698X-5-6     Document Type: Article

References (67)

1. UNAIDS: AIDS epidemic update. Geneva: UNAIDS 2004.
2. Van Rompay KK, McChesney MB, Aguirre NL, Schmidt KA, Bischofberger N, Marthas ML: Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection. J Infect Dis 2001, 184:429-438.
3. Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML: Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. J Infect Dis 2002, 186:1508-1513.
4. Subbarao S, Otten R, Ramos A, Jackson E, Adams D, Kim C, Bashirian S, Johnson J, Monsour M, Janssen R, Paxton L, Greenberg A, Folks T: Chemoprophylaxis with oral tenofovir disoproxil fumarate (TDF) delays but does not prevent infection in Rhesus Macaques given repeated rectal challenges of SIV. In 12th Conference on Retroviruses and Opportunistic Infections Boston; 2005:136LB.
5. Cohen J: AIDS research. Cambodian leader throws novel prevention trial into limbo. Science 2004, 305:1092.
6. Cohen J: Cameroon Suspends AIDS Study. Science, Science Now 2005. Feb. 4, 2005
7. Cohen J: AIDS clinical trials. More woes for novel HIV prevention approach. Science 2005, 307:1708.
8. Chase M: Key AIDS study in Cambodia now in jeopardy. In The Wall Street Journal New York; 2004.
9. Singh JA, Mills EJ: Abandoned trials of Pre-Exposure Prophylaxis for HIV: What went wrong? PLOS Medicine 2005, 2:e234.
10. IRIN-News: CAMEROON: Clinical trial of anti-HIV drug on sex workers in question. 2005 [http://www.irinnews.org/report.asp?ReportID= 45252&SelectRegion=West_Africa].
11. Atatah C: Douala AIDS Drug Controversy: Medical Council Says Trials Violated Ethical Norms. The Post News Line 2005 [http://www.postnewsline.com/ 2005/02/strongdouala_ai.html].
12. ACT-UP-Paris: tenofovir: inethical trial. ACT-UP Paris 2004 [http://www.actupparis.org/article1734.html].
13. Wilson K, Code C, Dornan C, Ahmad N, Hebert P, Graham I: The reporting of theoretical health risks by the media: Canadian newspaper reporting of potential blood transmission of Creutzfeldt-Jakob disease. BMC Public Health 2004, 4:1.
14. Nerlich B, Clarke DD: Anatomy of a media event: how arguments clashed in the 2001 human cloning debate. New Genet Soc 2003, 22:43-59.
15. James JS: Cambodia stops important tenofovir prevention trial. AIDS Treatment News 2004.
16. Munthit K: Cambodian PM orders anti-AIDS drug test halted; cites human values. Phnom Penh: Canadian Press; 2004.
17. Naik MCaG: Key AIDS Study in Cambodia Now in Jeopardy. Wall Street Journal 2004:B1. B1
18. Ahmad K: Trial of antiretroviral for HIV prevention on hold. The Lancet Infectious Diseases 2004, 4:597.
19. Stephan H: Growing Pains in AIDS drug Development: HIV drug trial in Cambodia halted. Nature Biotechnology 2004.
20. McKew M: Drug Trial to start in Cambodia. The 7:30 report 2004.
21. Russell S: AIDS Chicago Antiviral Drug Used to Treat AIDS to be tested as Vaccine. San Francisco Chronicle 2004.
22. JMO: Pro-abortion Group Thwarted in attempt to Test Dubious HIV drugs on Cambodian Prostitutes. Phnom Penh: LifeSiteNews 2004.
23. Alcorn K: Cambodian study of tenofovir for HIV prevention halted, PM cites 'human rights'. AIDSMAP 2004.
24. Timberg C: Dose of Prevention where HIV thrives: Nigeria Brothel is test site for new pill. Washington Post. Washington; 2004:A15. A15
25. Cohen J: Cambodian Leader Throws Novel Prevention Trial into Limbo. Science 2004, 305:1092. 1092
26. Jeffreys E: Cambodian Sex Workers win against Bill Gates. Scarlet Alliance 2004.
27. Comments IN: Cambodia's premier halts planned trials of AIDS drug. Life Issues Net 2004.
28. Cairns G: Sex Workers force end to drug trial. Positive Nation 2004.
29. Canada.com: Cambodia's prime minister halts AIDS drug trial. Science and Development Network 2004.
30. Thomas J: Cambodian HIV Clinical Trial impasse: UNAIDS mediation is essential. AIDS Asia 2004.
31. Ojcius D: HIV vaccine trial halted. Nat Rev Microbiol 2004, 2:776.
32. Munthit K: PM wants anti-AIDS drug trials stopped. In The Gazette Montreal; 2004:A14. A14
33. Reenie S: The Gilead Saga. American Journal of Bioethics Editors Blog. February 18, 2005
34. Cannistra SA: The ethics of early stopping rules: who is protecting whom? J Clin Oncol 2004, 22:1542-1545.
35. Bernard EJ: Cameroon study of tenofovir for HIV prevention suspended, Health Minister claims 'dysfunctions' in study protocol. Douala: Aidsmap 2005.
36. AEGiS-IRIN: CAMEROON: Clinical trial of anti-HIV drug on sex workers in question. Yaounde: Integrated Regional Information Network 2005.
37. Colombant N: Cameroon Activists Want Protection of Drug Test Victims. Abidjan: VOA 2005.
38. Coalition GCfMatAVA: Statement on the PREP trials in Cambodia and Cameroon. AF-AIDS 2005.
39. publique J-LR-Mds: Reply to posting by Act-UP Paris. 2004.
40. Samba-Kounzi R: emed@usahealthgap.org. 2004.
41. Shetty P: Cameroon suspends trial of AIDS drug after protests. Science and Development Network 2005.
42. Tall DCT: "Gilead Scandal in Cameroun" AfriCASO condemns. Actions Treatments 2005.
43. AF-AIDS: Tenofovir trials: Interview with Beth Robinson from FHI. HealthGap. February 5 2005
44. Chase M: AIDS-Preventative Test Halted by Cameroon Amid Protests. The Wall Street Journal 2005.
45. Simeon V: SIDA: Le Scandale est dans l'eprouvette. In La nouvelle Expression Douala; 2005.
46. AIDS drug trial stopped in Cambodia. Washington Times 2004.
47. Major HIV drug trial to be halted. BBC News 2004.
48. J C: The Asian Equation: One size doesn't fit all. International Antiviral Therapy Evaluation Center 2004.
49. News B: Major HIV drug trial to be halted. BBC News 2004.
50. Cambodian sex workers reject HIV drug trials. Asian Labor News 2004.
51. Ahmad K: Trial of antiretroviral for HIV prevention on hold. Lancet Infect Dis 2004, 4:597.
52. Ethics, drug trials and HIV: the case of tenofovir.
53. James JS: Cambodia stops important tenofovir prevention trial. AIDS Treat News 2004:4-5.
54. Group NHVaMA: Phase 2 trial of oral tenofovir use on a chemoprophylaxis for HIV infection in Nigeria: The outcome of community involvement with the scientific research process. 2004.
55. Sex workers trump Gates' humanitarian bid. Business Report . 2004 March 30
56. Munthit K: PM wants anti-AIDS drug trials stopped. The Gazette .
57. McCombs M, Shaw D: The Agenda-Setting Function of the Mass Media. Public Opinion Quarterly 1972, 36:176-187.
58. Mills E, Cooper C, Guyatt G, Gilchrist A, Rachlis B, Sulway C, Wilson K: Barriers to participating in an HIV vaccine trial: a systematic review. Aids 2004, 18:2235-2242.
59. Mills EJ, Singh S, Dolma S, Nixon S, Kapoor S: Enrolling women into HIV prevention trials: A logistical challenge but ethical imperative. In Presented at the 2005 Canadian HIV AIDS Research Conference Vancouver; 2005.
60. Duan N: Listening to consumers and HIV vaccine preparedness. Lancet 2005, 365:1119-1121.
61. Schuklenk U: The standard of care debate: against the myth of an "international consensus opinion". J Med Ethics 2004, 30:194-197.
62. Lie RK, Emanuel E, Grady C, Wendler D: The standard of care debate: the Declaration of Helsinki versus the international consensus opinion. J Med Ethics 2004, 30:190-193.
63. Steinbrook R: Medical journals and medical reporting. N Engl J Med 2000, 342:1668-1671.
64. Lomas J: Connecting Research and Policy. Canadian Journal of Policy Research 2000, 1:140-144.
65. Wilkie T: Sources in science: who can we trust? Lancet 1996, 347:1308-1311.
66. Social Issues Research Centre, Royal Society, Royal Institution of Great Britain. Guidelines on science and health communication. Oxford: Social Issues Research Centre 2001 [http://www.sirc.org/publik/revised_guidelines.shtml]. Accessed April 28, 2005
67. IAVI: International AIDS Vaccine Initiative. 2005 [http://www.iavi.org]. Accessed April 28, 2005